Neutralisation of adeno-associated virus transduction by human vitreous humour
- 15 June 2020
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 28 (5) , 242-255
Abstract
Neutralising antibodies (NAbs), caused by past adeno-associated virus (AAV) infection, represent a critical challenge for AAV-mediated gene therapy, with even low NAb titres capable of inhibiting gene transfer, however in protein-rich environments such as the vitreous it is expected that other constituents could also interact with the transduction process. Inhibition of AAV2/2, AAV2/5, AAV2/6 and AAV2/8 transduction by human vitreous humour (VH) obtained from 80 post-mortem eye cups was investigated in this report, with clinically relevant vitreous dilutions as low as 1:2. Unexpectedly, the highest prevalence of inhibition of transduction was observed against AAV2/6, with 66% of tested samples displaying neutralisation at a 1:2 VH dilution. Only two samples showed inhibition of AAV2/8, indicating this serotype is an attractive vector for use in non-vitrectomised eyes of unscreened individuals. Levels of anti-AAV NAbs observed in the VH were much lower than previously observed in serum of a similar Australian population. Among ten tested eye cup pairs, we observed only small variation in anti-AAV NAbs levels between the left and right eye cups. Interaction with 1:2 diluted VH had an augmentation effect on AAV2/8 transduction (p = 0.004), a phenomenon which was not due to albumin or transferrin and which, if developed, might benefit the use of AAV2/8 in clinical settings.Keywords
Funding Information
- Layton Vision Foundation
- CQUniversity
This publication has 52 references indexed in Scilit:
- Chikungunya and the eye: a reviewJournal of Ophthalmic Inflammation and Infection, 2013
- Laboratory support in the diagnosis of uveitisIndian Journal Of Ophthalmology, 2013
- Proteomic Analyses of the Vitreous HumourMediators of Inflammation, 2012
- Human Galectin 3 Binding Protein Interacts with Recombinant Adeno-Associated Virus Type 6Journal of Virology, 2012
- Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5Journal of General Virology, 2012
- Neutralizing Antibodies Against AAV Serotypes 1, 2, 6, and 9 in Sera of Commonly Used Animal ModelsMolecular Therapy, 2012
- Intravitreal Injection of AAV2 Transduces Macaque Inner RetinaInvestigative Ophthalmology & Visual Science, 2011
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular DegenerationMolecular Therapy, 2011
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the VitreousMolecular Therapy, 2009
- Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus VectorsJournal of Virology, 2008